You are here: Home » PTI Stories » National » News
Business Standard

New DNA test to screen your child for 193 genetic diseases

Press Trust of India  |  New York 

A simple DNA test designed to detect 193 childhood-onset diseases, including epilepsy, muscular and cancer, has been developed by a US-based genomic testing company.

The genetic test can be performed at home with a gentle cheek swab and allows parents to gain early insight into their baby's health, the company said.

As a supplemental test, Natalis screens for over five times the number of genetic than a standard hospital test in the US, they said.

For all conditions covered by the test - including atypical epilepsy, spinal muscular atrophy, and - there are validated medical interventions that may positively influence a baby's future wellbeing when introduced early enough.

According to the company, the use of Natalis should be reviewed and approved by a to ensure the test is medically appropriate for the child.

"Until now, families have been likely to be caught off-guard by these early-onset diseases, and prognosis is often poor by the time symptoms have manifested," said Eric Schadt, of

"Thanks to breakthroughs in science and medicine, we can now identify babies at risk for these broader set of and deliver interventions - sometimes as simple as vitamin supplements - in time to make a real difference," said Schadt.

Sema4 Natalis uses advanced to analyse a baby's genes with the accuracy of next generation technology, the company said.

The test may help address the issue of by using next-generation and analysis to supplement traditional newborn screening, it said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 12 2018. 17:20 IST